Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.

Area of Science:

• Neurogenetics
• Computational Biology
• Cellular Neuroscience

Background:

• Complex central nervous system (CNS) disorders, including autism and schizophrenia, exhibit significant genetic heterogeneity with numerous associated loci.
• The relationship between this genetic diversity and underlying cellular mechanisms remains unclear, despite symptom commonalities suggesting potential functional convergence.

Purpose of the Study:

• To develop and validate a computational approach for identifying specific cell types implicated in complex CNS disorders.
• To investigate potential common cellular mechanisms underlying genetically heterogeneous brain disorders.

Main Methods:

• Developed and validated a cell type-specific expression analysis (CSEA) method using gene expression profiling data from mice and humans.
• Applied CSEA to human genetics and postmortem gene expression data to identify candidate cell populations.

Main Results:

• The CSEA approach successfully identified cell types for disorders with known cellular etiologies, such as narcolepsy and retinopathies.
• Application to autism suggests multiple distinct cellular pathways may contribute to the disorder, despite its genetic heterogeneity.

Conclusions:

• Cell type-specific expression analysis is a valuable tool for uncovering cellular mechanisms in genetically complex CNS disorders.
• This approach can help identify shared cellular pathways that may underlie disorders with diverse genetic underpinnings, aiding in understanding and potential therapeutic development.